Prioritise Dengue Fever Prevention

Where is dengue prevalent?

The risk of dengue is now present in more than 125 countries worldwide.[1]

Although actual numbers of dengue cases are thought to be underreported,[1] both the numbers of dengue cases and the areas where dengue is prevalent are increasing worldwide, which poses a significant global public health challenge. [1,2,3] Discover the prevalence of dengue in this short video.

Raising awareness about the risks of dengue when travelling to endemic regions is important to help protect travellers and to try to limit the re-emergence of vector-borne diseases in Europe. [4]

Did you know?

Before 1930, dengue fever was endemic in southern Europe and affected more than a million people between 1927–1928. [4] However, between 1960–2000, there were only single incidental or sporadic reports of A. aegypti in Italy, Israel, and Turkey.[5]

Now, after many years with few cases reported, dengue is back in Europe. [4,6]

Since the first autochthonous outbreak was reported in 2010, there have been more than 20 outbreaks in mainland Europe, the largest occurring in Italy in 2020 (11 cases).[7]

It’s time to talk to travellers about dengue 

Download this free factsheet to help you to answer the most common queries about dengue

Download now
A doctor talking to his patient

Understand the risks

Make sure you understand the risks to your travellers, who is at higher risk of severe dengue.

See the risks

Prevent and protect

Learn how you can help to prevent the spread and protect your travellers.

Prevent dengue

Want to know more?

Sign-up to TakedaID to stay informed about dengue and help you advise travellers.

Sign up for updates

GB & NI: Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard.

ROI: Adverse events should be reported to the Pharmacovigilance Unit at the Health Products Regulatory Authority. Reporting forms and information can be found at: www.hpra.ie. 

GB, NI and ROI: Adverse events should also be reported to Takeda UK Ltd at: AE.GBR-IRL@takeda.com 

References

  1. WHO. Dengue and severe dengue factsheets. Available at: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue [Accessed January 2023].  
  2. Guzman MG, et al. Dengue infection. Nat Rev Dis Primers. 2016 ;2:16055.  
  3. Zeng Z, et al. Global, regional, and national dengue burden from 1990 to 2017: A systematic analysis based on the global burden of disease study 2017. EClinicalMedicine. 2021;32:100712.   
  4. World Health Organization. Dengue around the world. Available at: https://www.euro.who.int/__data/assets/pdf_file/0009/234198/Dengue-in-the-WHO-European-Region.pdf 
  5. Schaffner F, et al. Dengue and dengue vectors in the WHO European region: past, present, and scenarios for the future. Lancet Infect Dis. 2014;14:1271–80.  
  6. Tozan Y, et al. A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travellers. Am. J. Trop. Med. Hyg. 2019;100(6):1525–1533.  
  7. Gossner CM, et al. Dengue virus infections among European travellers, 2015 to 2019. Euro Surveil. 2022;27(2):2001937.  

C-APROM/GB/DENV/0019 | Date of preparation: March 2023